Clinical methods applied to research studiesModule GASTROENTEROLOGIA APPLICATA AI TRIALS CLINICI
Academic Year 2022/2023 - Teacher: Gaetano BERTINOExpected Learning Outcomes
Course Structure
Conduct of the lesson in frontal mode with the help of slides in Power-Point format, illustration and commentary on the main clinical studies and the main guidelines.
If the teaching is given in a mixed or remote mode, the necessary changes with respect to what was previously stated may be introduced, in order to comply with the program envisaged and reported in the syllabus.
Required Prerequisites
Knowledge of anatomy, physiology, of the digestive system and in particular of the liver and pancreas.
Knowledge of elements of biostatistics.
Attendance of Lessons
Detailed Course Content
Clinical trials and guidelines for the following gastroenterological diseases:
• Gastroesophageal reflux disease and hiatal hernia; prevention and non-drug therapy of gastroesophageal reflux and esophagitis.
• Helicobacter pylori diseases.
• Peptic ulcer.
• Celiac disease
• Irritable bowel syndrome.
• Chronic inflammatory bowel diseases: Crohn's disease, Ulcerative Rectum-Colitis and their complications
• Diverticular disease of the colon
• Clinical trials of chronic major hepatitis virus (HCV, HBV) infection.
• Steatosis (NAFLD), non alcoholic steatohepatitis (NASH).
• Alcohol liver disease.
• Autoimmune liver diseases: autoimmune hepatitis, primary biliary cholangitis, sclerosing cholangitis (outline).
• Wilson's disease (outline). Hereditary hemochromatosis and secondary hepatic siderosis (outline).
• Cirrhosis of the liver and its complications. Sarcopenia in the patient with liver cirrhosis.
• Acute and chronic pancreatitis.
Textbook Information
- National and international guidelines published in journals recognized by the international scientific community.
Course Planning
| Subjects | Text References | |
|---|---|---|
| 1 | Gastroesophageal reflux disease and hiatal hernia; prevention and non-drug therapy of gastroesophageal reflux and esophagitis. | Manuale di Gastroenterologia, UNIGASTRO, Editrice Gastroenterologica Italiana, edizione 2022-2025 |
| 2 | Helicobacter pylori infection. | Manuale di Gastroenterologia, UNIGASTRO, Editrice Gastroenterologica Italiana, edizione 2022-2025 |
| 3 | Peptic ulcer | Manuale di Gastroenterologia, UNIGASTRO, Editrice Gastroenterologica Italiana, edizione 2022-2025 |
| 4 | Celiac disease | Manuale di Gastroenterologia, UNIGASTRO, Editrice Gastroenterologica Italiana, edizione 2022-2025 |
| 5 | Irritable bowel syndrome. | Manuale di Gastroenterologia, UNIGASTRO, Editrice Gastroenterologica Italiana, edizione 2022-2025 |
| 6 | Crohn's disease, Ulcerative Rectum-Colitis | Manuale di Gastroenterologia, UNIGASTRO, Editrice Gastroenterologica Italiana, edizione 2022-2025 |
| 7 | Diverticular disease of the colon | Manuale di Gastroenterologia, UNIGASTRO, Editrice Gastroenterologica Italiana, edizione 2022-2025 |
| 8 | Clinical trials of chronic major hepatitis virus (HCV, HBV) infection. | Manuale di Gastroenterologia, UNIGASTRO, Editrice Gastroenterologica Italiana, edizione 2022-2025 |
| 9 | Steatosis (NAFLD), Non-alcoholic steatohepatitis (NASH). | Manuale di Gastroenterologia, UNIGASTRO, Editrice Gastroenterologica Italiana, edizione 2022-2025 |
| 10 | Autoimmune diseases of the liver: primary biliary cholangitis, sclerosing cholangitis (outline) | Manuale di Gastroenterologia, UNIGASTRO, Editrice Gastroenterologica Italiana, edizione 2022-2025 |
| 11 | Cirrhosis and its complications. Sarcopenia in the patient with liver cirrhosis. | Manuale di Gastroenterologia, UNIGASTRO, Editrice Gastroenterologica Italiana, edizione 2022-2025 |
| 12 | Acute and chronic pancreatitis. | Manuale di Gastroenterologia, UNIGASTRO, Editrice Gastroenterologica Italiana, edizione 2022-2025 |
Learning Assessment
Learning Assessment Procedures
Examples of frequently asked questions and / or exercises
Clinical trials that have improved the diagnostic therapeutic assistance (PDTA) pathways in the following gastroenterological pathologies:
Gastroesophageal reflux disease
Helicobacter pylori pathologies.
Peptic ulcer.
Celiac disease.
Irritable bowel syndrome.
Crohn's disease, Ulcerative Rectum-Colitis and their complications.
Diverticular disease of the colon.
Clinical trials of chronic major hepatitis virus (HCV, HBV) infection.
Steatosis (NAFLD), Non-alcoholic steatohepatitis (NASH).
Autoimmune diseases of the liver: primary biliary cholangitis, sclerosing cholangitis (outline).
Wilson's disease (outline).
Cirrhosis of the liver and its complications. Sarcopenia in the patient with liver cirrhosis.
Acute and chronic pancreatitis.